CATX stock · UPST stock

CATX vs UPST · $280.6M cap vs P/E 74, rev $672.9M

Perspective Therapeutics Inc. (CATX) versus Upstart Holdings Inc (UPST) — a side-by-side from cached financials, not a winner call.

Perspective Therapeutics Inc. (CATX) is a medical devices company listed on US.

Upstart Holdings Inc (UPST) is a credit services company listed on NASDAQ.

CATX does not have a complete income-statement cache yet.

Latest reported UPST revenue for 2026-06-30 was $672.9M. Net income was $9.9M. UPST currently screens at market cap $2.92B and trailing P/E 74.3.

CATX currently screens at market cap $280.6M. UPST currently screens at market cap $2.92B and trailing P/E 74.3.

Not investment advice. Open the CATX and UPST stock pages for the full models.

Not investment advice.

Popular Stock Comparisons